Clinical Evaluation of an Off-the-Shelf Allogeneic Adipose Matrix for Soft Tissue Reconstruction
Background:. Biomaterials derived from human adipose extracellular matrix have shown promise in vitro and in animal studies as an off-the-shelf adipogenic matrix for sustained volume replacement. Herein, we report the results of a randomized prospective study conducted with allograft adipose matrix...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2020-01-01
|
Series: | Plastic and Reconstructive Surgery, Global Open |
Online Access: | http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000002574 |
id |
doaj-d26f7ef31ebe483e9207c52bf486c8a9 |
---|---|
record_format |
Article |
spelling |
doaj-d26f7ef31ebe483e9207c52bf486c8a92020-11-25T03:07:14ZengWolters KluwerPlastic and Reconstructive Surgery, Global Open2169-75742020-01-0181e257410.1097/GOX.0000000000002574202001000-00014Clinical Evaluation of an Off-the-Shelf Allogeneic Adipose Matrix for Soft Tissue ReconstructionLauren E. Kokai, PhD0Wesley N. Sivak, MD, PhD1Benjamin K. Schilling, MS2Arivarasan Karunamurthy, MD3Francesco M. Egro, MBChB, MSc, MRCS4M. Asher Schusterman, MD5Danielle M. Minteer, PhD6Patsy Simon, RN, BS7Richard A. D’Amico, MD8J. Peter Rubin, MD9From the * Department of Plastic Surgery, University of Pittsburgh, Pittsburgh, Pa.From the * Department of Plastic Surgery, University of Pittsburgh, Pittsburgh, Pa.From the * Department of Plastic Surgery, University of Pittsburgh, Pittsburgh, Pa.§ Division of Molecular & Genomic Pathology, Pittsburgh, Pa.From the * Department of Plastic Surgery, University of Pittsburgh, Pittsburgh, Pa.From the * Department of Plastic Surgery, University of Pittsburgh, Pittsburgh, Pa.From the * Department of Plastic Surgery, University of Pittsburgh, Pittsburgh, Pa.From the * Department of Plastic Surgery, University of Pittsburgh, Pittsburgh, Pa.¶ Department of Plastic Surgery, Mount Sinai School of Medicine, New York, N.Y.From the * Department of Plastic Surgery, University of Pittsburgh, Pittsburgh, Pa.Background:. Biomaterials derived from human adipose extracellular matrix have shown promise in vitro and in animal studies as an off-the-shelf adipogenic matrix for sustained volume replacement. Herein, we report the results of a randomized prospective study conducted with allograft adipose matrix (AAM) grafted into the pannus of presurgical abdominoplasty patients 3 or 6 months before scheduled surgery. This is the first report of a longitudinal histologic analysis of AAM in clinical use. Methods:. Ten healthy patients undergoing elective abdominoplasty were recruited to receive AAM before surgery. Enrolled subjects were randomized into either a 3-month follow-up cohort or a 6-month follow-up cohort. Subjects were monitored for adverse events associated with AAM grafting in addition to undergoing serial biopsy. Following surgical excision of the pannus, representative samples from the AAM surgical sites were stained and evaluated with hematoxylin and eosin for tissue morphology, Masson’s trichrome for collagen, and perilipin for adipocytes. Results:. All subjects tolerated AAM with no severe adverse events reported. At 3 months following implantation, AAM remained visible within the confines of the subjects’ native surrounding adipose tissue with sparse adipocytes apparent within the matrix. By 6 months, AAM had remodeled and was primarily composed of perilipin-positive adipocytes. Histologic analysis confirmed tissue remodeling (hematoxylin and eosin), adipogenesis (perilipin), and angiogenesis (Masson’s trichrome) occurred with the presence of AAM. Conclusions:. AAM is a safe, allogeneic, off-the-shelf regenerative matrix that is adipogenic and noninflammatory and promotes angiogenesis.http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000002574 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Lauren E. Kokai, PhD Wesley N. Sivak, MD, PhD Benjamin K. Schilling, MS Arivarasan Karunamurthy, MD Francesco M. Egro, MBChB, MSc, MRCS M. Asher Schusterman, MD Danielle M. Minteer, PhD Patsy Simon, RN, BS Richard A. D’Amico, MD J. Peter Rubin, MD |
spellingShingle |
Lauren E. Kokai, PhD Wesley N. Sivak, MD, PhD Benjamin K. Schilling, MS Arivarasan Karunamurthy, MD Francesco M. Egro, MBChB, MSc, MRCS M. Asher Schusterman, MD Danielle M. Minteer, PhD Patsy Simon, RN, BS Richard A. D’Amico, MD J. Peter Rubin, MD Clinical Evaluation of an Off-the-Shelf Allogeneic Adipose Matrix for Soft Tissue Reconstruction Plastic and Reconstructive Surgery, Global Open |
author_facet |
Lauren E. Kokai, PhD Wesley N. Sivak, MD, PhD Benjamin K. Schilling, MS Arivarasan Karunamurthy, MD Francesco M. Egro, MBChB, MSc, MRCS M. Asher Schusterman, MD Danielle M. Minteer, PhD Patsy Simon, RN, BS Richard A. D’Amico, MD J. Peter Rubin, MD |
author_sort |
Lauren E. Kokai, PhD |
title |
Clinical Evaluation of an Off-the-Shelf Allogeneic Adipose Matrix for Soft Tissue Reconstruction |
title_short |
Clinical Evaluation of an Off-the-Shelf Allogeneic Adipose Matrix for Soft Tissue Reconstruction |
title_full |
Clinical Evaluation of an Off-the-Shelf Allogeneic Adipose Matrix for Soft Tissue Reconstruction |
title_fullStr |
Clinical Evaluation of an Off-the-Shelf Allogeneic Adipose Matrix for Soft Tissue Reconstruction |
title_full_unstemmed |
Clinical Evaluation of an Off-the-Shelf Allogeneic Adipose Matrix for Soft Tissue Reconstruction |
title_sort |
clinical evaluation of an off-the-shelf allogeneic adipose matrix for soft tissue reconstruction |
publisher |
Wolters Kluwer |
series |
Plastic and Reconstructive Surgery, Global Open |
issn |
2169-7574 |
publishDate |
2020-01-01 |
description |
Background:. Biomaterials derived from human adipose extracellular matrix have shown promise in vitro and in animal studies as an off-the-shelf adipogenic matrix for sustained volume replacement. Herein, we report the results of a randomized prospective study conducted with allograft adipose matrix (AAM) grafted into the pannus of presurgical abdominoplasty patients 3 or 6 months before scheduled surgery. This is the first report of a longitudinal histologic analysis of AAM in clinical use.
Methods:. Ten healthy patients undergoing elective abdominoplasty were recruited to receive AAM before surgery. Enrolled subjects were randomized into either a 3-month follow-up cohort or a 6-month follow-up cohort. Subjects were monitored for adverse events associated with AAM grafting in addition to undergoing serial biopsy. Following surgical excision of the pannus, representative samples from the AAM surgical sites were stained and evaluated with hematoxylin and eosin for tissue morphology, Masson’s trichrome for collagen, and perilipin for adipocytes.
Results:. All subjects tolerated AAM with no severe adverse events reported. At 3 months following implantation, AAM remained visible within the confines of the subjects’ native surrounding adipose tissue with sparse adipocytes apparent within the matrix. By 6 months, AAM had remodeled and was primarily composed of perilipin-positive adipocytes. Histologic analysis confirmed tissue remodeling (hematoxylin and eosin), adipogenesis (perilipin), and angiogenesis (Masson’s trichrome) occurred with the presence of AAM.
Conclusions:. AAM is a safe, allogeneic, off-the-shelf regenerative matrix that is adipogenic and noninflammatory and promotes angiogenesis. |
url |
http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000002574 |
work_keys_str_mv |
AT laurenekokaiphd clinicalevaluationofanofftheshelfallogeneicadiposematrixforsofttissuereconstruction AT wesleynsivakmdphd clinicalevaluationofanofftheshelfallogeneicadiposematrixforsofttissuereconstruction AT benjaminkschillingms clinicalevaluationofanofftheshelfallogeneicadiposematrixforsofttissuereconstruction AT arivarasankarunamurthymd clinicalevaluationofanofftheshelfallogeneicadiposematrixforsofttissuereconstruction AT francescomegrombchbmscmrcs clinicalevaluationofanofftheshelfallogeneicadiposematrixforsofttissuereconstruction AT masherschustermanmd clinicalevaluationofanofftheshelfallogeneicadiposematrixforsofttissuereconstruction AT daniellemminteerphd clinicalevaluationofanofftheshelfallogeneicadiposematrixforsofttissuereconstruction AT patsysimonrnbs clinicalevaluationofanofftheshelfallogeneicadiposematrixforsofttissuereconstruction AT richardadamicomd clinicalevaluationofanofftheshelfallogeneicadiposematrixforsofttissuereconstruction AT jpeterrubinmd clinicalevaluationofanofftheshelfallogeneicadiposematrixforsofttissuereconstruction |
_version_ |
1724671746690252800 |